Brought to you by the members of Maximizing Access & Quality Initiative

IUD Toolkit

Up-to-date evidence and best practices related to the Intrauterine Device

Brought to you by USAID's Maximizing Access & Quality Initiative

Bibliography

American College of Obstetrics and Gynecology (ACOG). ACOG practice bulletin. Clinical management guidelines for obstetrician-gynecologists. Intrauterine device. Obstetrics and Gynecology 2005; 105: 223-32.
Ajello C, Limpaphayom K, Gaffikin L, et al. A humanistic approach to IUD clinical training: results of a comparative study in Thailand. Baltimore, MD: JHPIEGO, 1994.
Alvarez F, Brache V, Fernandez E, et al. New insights on the mode of action of intrauterine contraceptive devices in women. Fertil Steril 1988; 49: 768-73.
Andersson K, Batar I, Rybo G. Return to fertility after removal of a levonorgestrel-releasing intrauterine device and Nova-T. Contraception 1992; 46: 575-84.
Andrade A, Pizarro Orchard E. Quantitative studies on menstrual blood loss in IUD users. Contraception 1987; 36: 129-44.
Backman T, Huhtala S, Luoto R, et al. Advance information improves user satisfaction with the levonorgestrel intrauterine system. Obstetrics and Gynecology 2002; 99: 608-613.
Belhadj H, Sivin I, Diaz S, et al. Recovery of fertility after use of the levonorgestrel 20 mcg/d or Copper T 380 Ag intrauterine device. Contraception 1986; 34: 261-67.
Brambila C, Traracena B. Availability and acceptability of IUDs in Guatemala. New York: Population Council, 2003.
Bratt J, Foreit J, de Vargas T. Three strategies to promote sustainability of CEMOPLAF clinics in Ecuador. Studies in Family Planning 1998; 29: 58-68.
Chhabra S, Gupte N, Mehta A, et al. Medical termination of pregnancy and concurrent contraceptive adoption in rural India. Studies in Family Planning 1988; 19: 244-47.
Chi I. What we have learned from recent IUD studies: a researcher's perspective. Contraception 1993; 48: 81-108.
Chiou CF, Trussell J, Reyes E, et al. Economic analysis of contraceptives for women. Contraception 2003; 68: 3-10.
Coeytaux F. Celebrating mother and child on the fortieth day: the Sfax, Tunisia postpartum program. New York: Population Council, 1989.
Croxatto HB, Ortiz ME, Valdez E. IUD Mechanisms of Action. In: Bardin CWaMDR (Ed) Proceedings from the Fourth International Conference on IUDs. Butterworth-Heinemann, Inc, Newton, MA, 1994.
Demographic and Health Surveys. STATcompiler. 2005. http://www.measuredhs.com/statcompiler/
Eren N, Ramos R, Gray RH. Physicians vs. auxiliary nurse-midwives as providers of IUD services: A study in Turkey and the Philippines. Studies in Family Planning 1983; 14: 43-47.
Farley TM, Rosenberg MJ, Rowe PJ, et al. Intrauterine devices and pelvic inflammatory disease: An international perspective. Lancet 1992; 339: 785-88.
Farr G, Rivera R, Amatya R. Non-physician insertion of IUDs: Clinical outcomes among TCu380A insertions in three developing-country clinics. Advances in Contraception 1998; 14: 45-57.
Fisher AA, de Silva V. Satisfied IUD acceptors as family planning motivators in Sri Lanka. Studies in Family Planning 1986; 17: 235-242.
Foreit KG, Foreit JR, Lagos G, et al. Effectiveness and cost-effectiveness of postpartum IUD insertion in Lima, Peru. International Family Planning Perspectives 1993; 19: 19-24, 33.
Forrest JD. U.S. women's perceptions of and attitudes about the IUD. Obstetrical and Gynecological Survey 1996; 51: S30-4.
Furlong LA. Ectopic pregnancy risk when contraception fails: a review. Journal of Reproductive Medicine 2002; 47: 881-885.
Grimes DA. Intrauterine device and upper-genital-tract infection. Lancet 2000; 356: 1013-9.
Grimes DA, Schulz KF. Prophylactic antibiotics for intrauterine device insertion: a metaanalysis of the randomized controlled trials. Contraception 1999; 60: 57-63.
Grimes DA. Intrauterine devices (IUDs). In: Hatcher RA, Trussell J, Stewart F, et al. (Eds) Contraceptive Technology. Ardent Media, Inc, New York, 2004.
Grimes DA, Schulz K, Stanwood N. Immediate postabortal insertion of intrauterine devices. Cochrane Database of Systematic Reviews 2004; CD001777.
Gyapong J, Addico G, Osei I, et al. An assessment of trends in the use of the IUD in Ghana. New York: Population Council, 2003.
Harrison-Woolrych M, Ashton J, Coulter D. Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported? Contraception 2003; 67: 53-56.
Hatcher RA, Rinehart W, Blackburn R, et al. The essentials of contraceptive technology. Baltimore: Population Information Program. Center for Communication Programs. The Johns Hopkins University School of Public Health, 2001.
Hatcher R, Nelson A, Zieman M. A pocket guide to managing contraception: 2002-2003. Tiger, Georgia: Bridging the Gap Foundation, 2002.
Hubacher D, Cárdenas C, Hernández D, et al. The costs and benefits of IUD follow-up visits in the Mexican Social Security Institute. International Family Planning Perspectives 1999a; 25: 21-26.
Hubacher D, Grimes DA. Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstetrical and Gynecological Survey 2002; 57: 120-128.
Hubacher D, Holtman M, Fuentes M, et al. Increasing efficiency to meet future demand: family planning services provided by the Mexican Ministry of Health. International Family Planning Perspectives 1999b; 25: 119-24, 138.
Hubacher D, Lara-Ricalde R, Taylor DJ, et al. Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women. New England Journal of Medicine 2001; 345: 561-67.
Janowitz B, Hubacher D, Petrick T, et al. Should the recommended number of IUD revisits be reduced? Studies in Family Planning 1994; 25: 362-367.
Katz KR, Johnson LM, Janowitz B, et al. Reasons for the low level of IUD use in El Salvador. International Family Planning Perspectives 2002; 28: 26-31.
Medina R, Vernon R, Mendoza I, et al. Expansion of postpartum/postabortion contraception in Honduras. Washington, DC: Population Council, Frontiers in Reproductive Health, 2001.
Miller K, Miller R, Askew I, et al. Clinic-based family planning and reproductive health services in Africa: findings from situation analysis studies. New York: Population Council, 1998.
Milsom I, Andersson K, Jonasson K, et al. The influence of the Gyne-T 380S IUD on menstrual blood loss and iron status. Contraception 1995; 52: 175-79.
Mohllajee AP, Curtis KM, Peterson HB. Does insertion and use of an intrauterine device increase the risk of pelvic inflammatory disease among women with sexually transmitted infection? A systematic review. Contraception 2006; 73: 145-53.
Montufar E, Morales C, Vernon R, et al. Improving access to long-term contraceptives in rural Guatemala through the Ministry of Health. Washington, DC: FRONTIERS, Population Council, 2005.
Morrison CS, Sekadde-Kigondu C, Miller WC, et al. Use of sexually transmitted disease risk assessment algorithms for selection of intrauterine device candidates. Contraception 1999; 59: 97-106.
Núnez MDS, Zylberman NG, Sanchéz RR, et al. Consejería en la atención de mujeres en situación de aborto. Mexico: IPAS, 2005.
Pariani S, Heer DM, Van Arsdol MD. Does choice make a difference to contraceptive use? Evidence from east Java. Studies in Family Planning 1991; 22: 384-90.
Penney G, Brechin S, de Souza A, et al. FFPRHC Guidance (January 2004). The copper intrauterine device as long-term contraception. Journal of Family Planning and Reproductive Health Care 2004; 30: 29-41; quiz 42.
Richardson BA, Morrison CS, Sekadde-Kigondu C, et al. Effect of intrauterine device use on cervical shedding of HIV-1 DNA. AIDS 1999; 13: 2091-97.
Rivera R, Farr G, Chi I-C. The copper IUD, Safe and effective: The international experience of Family Health International. Research Triangle Park, North Carolina: Family Health International, 1992.
Ross J, Hardee K, Mumford E, et al. Contraceptive method choice in developing countries. International Family Planning Perspectives 2002; 28: 32-40.
Schmidt F, Sivin I, Waldman S. The Copper T 380 IUD. In: Bardin CW, Mishell DR (Eds) Proceedings from the Fourth International Conference on IUDs. Butterworth-Heinemann, Newton, MA, 1994.
Sekadde-Kigondu C, Mwathe EG, Ruminjo JK, et al. Acceptability and discontinuation of Depo-Provera, IUCD and combined pill in Kenya. East African Medical Journal 1996; 73: 786-94.
Senlet P, Cagatay L, Ergin J, et al. Bridging the gap: integrating family planning with abortion services in Turkey. International Family Planning Perspectives 2001; 27: 90-95.
Shelton J. The provider perspective: human after all. International Family Planning Perspectives 2001a; 27: 152-53, 161.
Shelton J, Angle MA, Jacobstein RA. Medical barriers to access to family planning. Lancet 1992; 340: 1334-1335.
Shelton J. Risk of clinical pelvic inflammatory disease attributable to an intrauterine device. Lancet 2001; 357: 443.
Sinei SK, Morrison CS, Sekadde-Kigondu C, et al. Complications of use of intrauterine devices among HIV-1-infected women. Lancet 1998; 351: 1238-41.
Sivin I. Dose- and age-dependent ectopic pregnancy risks with intrauterine contraception. Obstetrics and Gynecology 1991; 78: 291-298.
Sivin I. The Copper T 380 intrauterine device: a summary of scientific data. The Population Council, New York, 1992.
Stanback J, Qureshi Z, Sekadde-Kigondu C, et al. Checklist for ruling out pregnancy among family-planning clients in primary care. Lancet 1999; 354: 566.
Stanback J, Twum-Baah KA. Why do family planning providers restrict access to services? An examination in Ghana. International Family Planning Perspectives 2001; 27: 37-41.
Steele F, Curtis SL, Choe M. The impact of family planning service provision on contraceptive-use dynamics in Morocco. Studies in Family Planning 1999; 30: 28-42.
Task Force for Epidemiological Research on Reproductive Health. United Nations Development Programme/United Nations Population Fund/World Health Organization/World Bank Special Programme of Research, Development and Research Training in Human Reproduction, World Health Organization. Effects of contraceptives on hemoglobin and ferritin. Geneva, Switzerland. Contraception 1998; 58: 261-73.
Thapa S, Kumar S, Cushing J, et al. Contraceptive use among postpartum women: recent patterns and programmatic implications. International Family Planning Perspectives 1992; 18: 83-92.
Treiman K, Liskin L, Kols A, et al. IUDs—An update. Population Reports, Series B, No. 6. 1995; 35 p.
Trussell J. Contraceptive failure in the United States. Contraception 2004; 70: 89-96.
Trussell J. Cost versus effectiveness of different birth control methods. Population Studies 1974; 28: 85-106.
United Nations Development Programme (UNDP), United Nations Population Fund (UNFPA), World Health Organization (WHO), et al. The TCu 380A IUD and the frameless IUD "the FlexiGard": Interim three-year data from an international multicenter trial. Contraception 1995; 52: 77-83.
United Nations Department for Economic and Social Information and Policy Analysis. Population and development: Programme of Action adopted at the International Conference on Population and Development, Cairo, 5-13 September 1994. New York: United Nations, Department for Economic and Social Information and Policy Analysis, 1994.
United Nations Development Programme, United Nations Population Fund, World Health Organization, et al. Long-term reversible contraception: Twelve years of experience with the TCu380A and TCu220C. Contraception 1997; 56: 341-352.
United States Food and Drug Administration (FDA). Intrauterine contraceptive devices: professional and patient labeling. Regulation # 884.5360. Rockville, MD: FDA, 2005.
Villanueva Y , Mendoza I, Aguilar C, et al. Expansion of the role of nurse auxiliaries in the delivery of reproductive health services in Honduras. Washington, DC: Population Council, 2001.
Westrom L. Effect of acute pelvic inflammatory disease on fertility. Am J Obstet Gynecol 1975; 121: 707-13.
White MK, Ory HW, Rooks JB, et al. Intrauterine device termination rates and the menstrual cycle day of insertion. Obstetrics and Gynecology 1980; 55: 220-4.
World Health Organization. Medical eligibility criteria for contraceptive use. Geneva: WHO, 2004a.
World Health Organization. Selected practice recommendations for contraceptive use. Geneva: WHO, 2004b.
World Health Organization (WHO), Johns Hopkins Bloomberg School of Public Health. Center for Communication Programs. Information and Knowledge for Optimal Health (INFO). Decision-making tool for family planning clients and providers. Baltimore, INFO and Geneva, WHO: 2005.
Zetina-Lozano G. Menstrual bleeding expectations and short-term contraception discontinuation in Mexico. Studies in Family Planning 1983; 14: 127-33.
Zlidar V, Gardner R, Rutstein SO, et al. New survey findings: the reproductive revolution continues. Population Reports, Series M, No. 17. 2003; 42 p.